Gregg R. Honigblum

Director

Gregg Honigblum has been a member of our Board of Directors since December 2006. Mr. Honigblum has more than 20 years of experience as a financier for emerging growth companies primarily in the healthcare area.

Gregg has been instrumental in providing early stage financing for companies such as Myriad Genetics, Inc. and Acacia Biosciences, Inc., which merged with Rosetta Inpharmatics, Inc. and is now a wholly owned subsidiary of Merck.

Since 2001, Mr. Honigblum has been the Chief Executive Officer and founder of Creation Capital LLC, an investment banking firm specializing in the financing and development of early stage medical device and biotechnology companies. Creation Capital has served as the placement agent for our private financings and has provided, through its client base, more than $73 million of equity capital. Mr. Honigblum holds a B.A. in economics from the University of Texas at Austin.